How to Monitor Safety and Efficacy of Biologic Treatment in Rare, Therapy-Refractory Immune-Mediated Inflammatory Diseases?

Rheumatology (Oxford). 2018 Apr 1;57(4):591-593. doi: 10.1093/rheumatology/kex016.

Publication types

  • Editorial

MeSH terms

  • Biological Factors / therapeutic use*
  • Biological Products / therapeutic use*
  • Humans
  • Immune System Diseases / drug therapy*
  • Rare Diseases*
  • Treatment Outcome

Substances

  • Biological Factors
  • Biological Products